Prescription Information Modernization Act of 2023

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 118th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

R HarshbargerSponsor

32 cosponsors · 19 D, 13 R

1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill allows health care providers to receive prescribing information for drugs electronically rather than in paper form from manufacturers. Manufacturers must still give providers the option to continue to receive or request the information in paper form.

What it does: CRS summary · Introduced in House · Mar 9, 2023

Prescription Information Modernization Act of 2023

Additionally, the Food and Drug Administration must hold a public workshop to discuss with stakeholders how to optimize the format, accessibility, and usability of prescribing information.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Prescription Information Modernization Act of 2023

Latest action (Mar 17, 2023): Referred to the Subcommittee on Health.

Policy area: Health · Origin: House · Introduced: Mar 9, 2023

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.